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Background: De Quervain's tenosynovitis is a common cause of wrist pain in pregnant and postpartum
females. This study provides objective evidence regarding the therapeutic efﬁcacy of phonophoresis in
treating de Quervain's disease during pregnancy.
Methods: In a single blind, randomised, controlled trial (n ¼ 50), ketoprofen phonophoresis was given to
the intervention group and conventional ultrasound (US) was given to controls, coupled with thumb
splint immobilisation, and supervised strengthening and stretching exercises for 1 month. Symptomatic
and functional improvement was assessed by visual pain analogue, grip, tip, key, and palmer pinch
scales.
Results: There was a statistically signiﬁcant improvement in the intervention group compared to the
control group in grip and pinch strength, and pain reduction.
Conclusion: Ketoprofen phonophoresis as an adjunct to supervised exercise and splint immobilisation is
a safe and effective therapy for de Quervain's tenosynovitis during pregnancy. Phonophoresis augments
the beneﬁts of US in terms of reducing pain and inﬂammation, and improving functional strength.
中 文 摘 要
背景：De Quervain腱鞘炎是在孕婦和產後婦女引起手腕疼痛的常見原因。這項研究提供了在懷孕期間利用
透入療法醫治de Quervain腱鞘炎的客觀證據。
方法：單盲隨機對照試驗（n ¼ 50）。介入組病人接受酮洛芬 (ketoprofen)透入療法，而對照組病人則接受
普通超聲波。兩組均接受拇指夾板固定和受指導進行伸展運動一個月。症狀和功能改善評估依據視覺疼痛分
數，握力，指尖夾力，鑰匙夾力和手掌捏尺度。
結果：介入組在握力，夾力和疼痛分數上，比對照組有統計學上顯著的改善。
結論：酮洛芬透入療法配合拇指夾板固定和受指導進行的伸展運動，是一種安全，有效治療懷孕期間de
Quervain 腱鞘炎的方法。酮洛芬透入療法在減少疼痛，消炎和改善功能方面，增強了超聲波的治療果效。Introduction
Phonophoresis is a method of driving topically applied sub-
stances across tissues using ultrasound (US) to enhance percuta-
neous absorption of selected drugs such as corticosteroids, local
anaesthetics, and salicylates.1 Despite prevalent applications in
various musculoskeletal conditions including de Quervain'smail.com.
sociation and Hong Kong College of Orthdisease, few modalities have been the target of as much contro-
versy and speculation as phonophoresis.2,3 Standardised research is
needed to accurately determine the efﬁcacy of phonophoresis in
pregnant females suffering from de Quervain's disease; more so
because this vulnerable group is generally excluded from routine
clinical trials and prevailing knowledge about the same is scant.
Our study provides objective evidence regarding the applicability
of phonophoresis in treating de Quervain's disease in pregnant
women. It describes appropriate drug concentration, vehicle type,
US frequency, and the mode for bringing about maximal im-
provements in the condition.opaedic Surgeons. Published by Elsevier (Singapore) Pte Ltd. All rights reserved.
Table 2
Percentage change in pain perception pretreatment and post-treatment (ketoprofen
phonophoresis for intervention and inert gel for control)
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A single blind (patients were blinded as to the type of therapy
they were receiving), randomised, controlled trial enrolled 50
third-trimester pregnant females complaining of de Quervain's
tenosynovitis, from the outpatient clinic of the obstetrics depart-
ment at the Kasr-El-Aini University and Hospital, Cairo, Egypt
during 2011 (Table 1). Patients with metabolic disorders, obesity,
lymph oedema, hypertension, rheumatic disease, previous wrist
operation or fracture, osteoarthritis, neurological disease, history of
steroids injection, oral anti-inﬂammatory drugs, or analgesics
intake were excluded from the study. The women were randomly
divided into control and intervention (n ¼ 25 each) groups. The
intervention group received 2.5% ketoprofen phonophoresis with
Fastum gel whereas the control group received conventional US
with inert K-Y gel as a coupling medium over the radial styloid
process of the affected hand. In both groups, US devise, mode, in-
tensity, and frequency were kept identical (BTL-5000 series US
device, National Ultrasound, Berkley road, Georgia, USA; pulsed
mode, frequency 3 MHz, intensity 0.8 w/cm2 for 10 minutes);
applied for three sessions/week for 4 weeks. Here it is imperative to
mention that the US operator in both groups was the same person
to avoid applicator bias and confounding of outcomes. The two
groups were prescribed thumb spica splint immobilisation during
the day, and after the ﬁrst six sessions they received supervised
thumb strengthening and stretching exercises, repeated twice
daily. The two groups were assessed before and after the therapy
regime for pain (visual pain analogue scale: 0 ¼ no pain, 1 ¼ mild
pain, 2¼moderate pain, 3¼ severe pain, 4¼ unbearable pain), grip
strength (Jamar hand held dynamometer), and tip, key, and palmer
pinch strength (B&L pinch gauge, National Ultrasound, Berkley
road, Georgia, USA). Basic descriptive statistics were used to anal-
yse the results, with the conﬁdence interval set at 95% and p < 0.05
considered as signiﬁcant. Mean, standard deviations, percentages,
frequency, Student t test, etc., were applied as required.
The study was approved by the institutional ethics committee
and voluntary informed consent was obtained from participants
before commencement of the study, as per guidelines of the
Declaration of Helsinki.
Results
The intervention group (A) showed remarkable improvement
compared to the control group (B) in terms of reduction in pain
intensity and enhancement of grip and pinch strength. The differ-
ence between the two groups was statistically signiﬁcant on all
three assessment scales.
Pain perception intensity (PPi) scores
Pretreatment PPi scores of Group A ranged between 3 and 4 and
post-treatment scores ranged between 0 and 1. The decrease inTable 1
Randomised controlled trial on 50 third-trimester pregnant females with de Quer-
vain's tenosynovitis; Kasr-El-Aini University and Hospital, Egypt during 2011
Demographics* (n ¼ 50) Valuey, range (mean)
Age 25e35 y (29.16 ± 3.07)
Weight 66e95 kg (82.66 ± 6.07)
Height 150e170 cm (162.46 ± 5.59)
Body mass index 29e34 kg/m2 (30.83 ± 1.11)
* Physical demographic characteristics of patients.
y Difference between the control and intervention groups were statistically
nonsigniﬁcant; p > 0.1.pain was highly signiﬁcant (p ¼ 0.0001) and the percentage of
improvement was 92.5%. In Group B, pretreatment PPi scores
ranged between 3 and 4, and at the end of the treatment program
scores ranged between 0 and 4. Pre- and post-PPi scores showed no
statistical difference (p > 0.05). The percentage of improvement
was a meagre 7.9% (Table 2; Figure 1).
Grip strength
In Group A, pretreatment grip strength was 10.6 ± 2.22 kg,
whereas the post-treatment value was 23.93 ± 2.6 kg. There was a
highly signiﬁcant increase in grip strength (p ¼ 0.0001) with
125.75% improvement. In Group B, before starting the treatment
program, the grip strength was 11.66 ± 2.66 kg, whereas at the end
of the treatment program, it was 10.8 ± 4.82 kg. There was no
statistical difference between the two scores (p > 0.05). The per-
centage of improvement was merely 7.37% (Table 3; Figure 2).
Tip pinch
There was a highly signiﬁcant increase in tip pinch strength of
Group A; 126% improvement (pretreatment scores were
3.33 ± 0.85 kg whereas post-treatment scores were 7.53 ± 0.87 kg;
p < 0.0001). Conversely, Group B scores showed no similar
improvement (pretreatment 3.73 ± 0.7 kg and post-treatment
3.43 ± 1.27 kg; p > 0.05 and only 8.04% improvement) (Table 4;
Figure 2).
Key pinch
Key pinch strength in Group A showed a statistically signiﬁcant
improvement in post-treatment values; p < 0.0001 and a progress
of 110.17%. Corresponding scores of Group B showed minimal
change between pretreatment and post-treatment values; p > 0.05
and 11.9% improvement (Table 5; Figure 2).
Palmer pinch
Palmer pinch strength showed an improvement of 106.99%
between pretreatment and post-treatment values; (3.86 ± 0.91 vs.
8 ± 0.56; p < 0.0001). By contrast, Group B scores improved only by
10.63% (3.76 ± 0.67 vs. 3.63 ± 1.23; p > 0.05) (Table 6; Figure 2).
Discussion
De Quervain's tenosynovitis is a frequently encountered pain of
the hand andwrist. It results from compression and irritation of the
extensor pollicis brevis and abductor pollicis longus tendons asPain intensity Group A (intervention; n ¼ 25) Group B (control; n ¼ 25)
Pretreatment Post-treatment Pretreatment Post-treatment
Mean ± SD 3.6 ± 0.5 0.26 ± 0.45 3.26 ± 0.45 3.0 ± 1.36
Mean difference 3.33 0.26
t value 20.91 0.74
p 0.0001* 0.46
Percentage
of change (%)
92.5 7.97
*p value signiﬁcant.
Third trimester pregnant females (n ¼ 50) complaining of de Quervain's tenosyn-
ovitis of the dominant hand from the outpatient clinic of the obstetrics department,
Kasr-El-Aini University and Hospital, Egypt during 2011; ketoprofen 2.5% phono-
phoresis proved highly effective.
SD ¼ standard deviation.
Figure1. Pain perception improvement pre- and post-treatment (ketoprofen phonophoresis for the intervention group and inert gel for the control group).
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tients complain of tenderness and swelling proximal to the radial
styloid process, as well as pain in the wrist and on the radial side of
the hand. Owing to persistent pain and inﬂammation, the pinch
and grasp strength of the hand is considerably compromised,
coupled with tenderness over the anatomical snuff box. Although
the condition occurs in both females and males, it is signiﬁcantly
more common in women, especially during pregnancy and post-
partum. Some sources even quote a female:male ratio as high as
8:1.4,5
The allure of achieving outcomes “without the pill or needle”
appeals to patients and practitioners alike and this has triggered
the use of alternatives like physiotherapeutic regimes and pene-
tration enhancing vehicles such as iontophoresis and phonopho-
resis in treating de Quervain's disease.3,6 However, the actual
efﬁcacy of phonophoresis has not yet been conclusively established
in medical literature.2,3 Attending to this gap in evidence-based
information, our study proves that ketoprofen phonophoresis
coupled with short term thumb splintage and stretching exercise
leads to considerable symptomatic and functional improvement in
de Quervain's tenosynovitis.
Our results agreewith numerous previous researchwhich states
that phonophoresis stimulates acceleration of tissue repair andTable 3
Mean grip strength pretreatment and post-treatment (ketoprofen phonophoresis
for intervention and inert gel for control)
Grip strength Group A (intervention; n ¼ 25) Group B (control; n ¼ 25)
Pretreatment Post-treatment Pretreatment Post-treatment
Mean ± SD 10.6 ± 2.22 23.93 ± 2.6 11.6 ± 2.66 10.8 ± 4.82
Mean difference 13.33 0.86
t value 57.39 1.12
p 0.0001* 0.28
Percentage
of change (%)
125.75 7.37
*p value signiﬁcant.
Third trimester pregnant females (n ¼ 50) complaining of de Quervain's tenosyn-
ovitis of the dominant hand from the outpatient clinic of the obstetrics department,
Kasr-El-Aini University and Hospital, Egypt during 2011; ketoprofen 2.5% phono-
phoresis proved highly effective.
SD ¼ standard deviation.enhances transdermal delivery of drugs. Systemic absorption of
drugs has been found to be as low as 1% after topical application17
and this further supports employing phonophoresis as an absorp-
tion enhancer, which results in signiﬁcantly high local tissue con-
centrations.9 Further support comes from research by Mitragotri,1
who reported that low-frequency US (20 kHz) enhanced trans-
dermal transport of drugs, a phenomenon he referred to as sono-
phoresis. In spite of favourable outcomes in numerous trials, the
efﬁcacy of phonophoresis still remains a hotly debated topic.
Clinical research reports equivocal results (Table 7).2,7e16 Whereas
some advocates suggest phonophoresis may be effective, critics are
quick to point to the placebo effect and to the fact that positive
outcomes are due to the thermal and tactile effects of US itself. In an
interesting study, often cited by opponents of the technique, 16
asymptomatic men and women between the ages of 18 and 33
years were administered topical 10% hydrocortisone. US was
delivered over a 50-cm2 area for 5 minutes and subsequently, blood
was drawn under control (US only) and experimental (hydrocor-
tisone plus US) conditions. No rise in serum cortisol concentrations
was detected, thereby questioning the very basis of the phono-
phoresis mechanism that states it as a “penetration enhancing
vehicle”.18 Despite ambiguous ﬁndings of other researchers, our
study proves that ketoprofen phonophoresis has an excellent effect
on relieving symptoms of de Quervain's tenosynovitis during
pregnancy and that physiotherapists can safely and conﬁdently use
it.
Some strengths of this study were adequate blinding, appro-
priate randomisation, homogeneous selection of participants, and
uniform measurement techniques which might have removed bias
from the results. However, our study had certain drawbacks as well,
including small sample size, short duration of therapy, and lack of
long-term follow-up. Also, most measurements were done in
relation to pain reduction and functional improvement in terms of
grip and pinch strength, rather than assessment of the range of
motion prior to and after treatment (considering that patients of de
Quervain's disease often complain of limited thumb and wrist
motion). Furthermore, estimation of the depths of muscle or tissue
penetration was not done, but the researchers plan to tackle these
“missed out” points as a future research task in a larger study group.
More investigation is needed to elucidate the underlying prin-
ciples and therapeutic potential of phonophoresis. It could well be
Figure 2. Functional improvement pre- and post-treatment (ketoprofen phonophoresis for the intervention group and inert gel for control group).
Table 4
Tip pinch strength pre- and post-treatment (ketoprofen phonophoresis for inter-
vention and inert gel for control)
Tip pinch strength Group A (intervention; n ¼ 25) Group B (control; n ¼ 25)
Pretreatment Post-treatment Pretreatment Post-treatment
Mean ± SD 3.33 ± 0.85 7.53 ± 0.87 3.73 ± 0.7 3.43 ± 1.27
Mean difference 4.2 0.3
t value 21.0 1.14
p 0.0001* 0.27
Percentage
of change (%)
126.13 8.04
*p value signiﬁcant.
Third trimester pregnant females (n ¼ 50) complaining of de Quervain's tenosyn-
ovitis of the dominant hand from the outpatient clinic of the obstetrics department,
Kasr-El-Aini University and Hospital, Egypt during 2011; ketoprofen 2.5% phono-
phoresis proved highly effective.
SD ¼ standard deviation.
Table 5
Key pinch strength pretreatment and post-treatment (ketoprofen phonophoresis for
intervention and inert gel for control)
Key pinch
strength
Group A (intervention; n ¼ 25) Group B (control; n ¼ 25)
Pretreatment Post-treatment Pretreatment Post-treatment
Mean ± SD 3.93 ± 1.17 8.26 ± 0.77 3.36 ± 0.78 2.96 ± 1.31
Mean difference 4.33 0.4
t value 20.02 1.6
p 0.0001* 0.13
*p value signiﬁcant.
Third trimester pregnant females (n ¼ 50) complaining of de Quervain's tenosyn-
ovitis of the dominant hand from the outpatient clinic of the obstetrics department,
Kasr-El-Aini University and hospital, Egypt during 2011; ketoprofen 2.5% phono-
phoresis proved highly effective.
SD ¼ standard deviation.
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ject” dependent and that certain body regions or target populations
respond better than others; hence, conclusions cannot be gener-
alised and appropriate interventions for speciﬁc areas or groups
need to be determined. Future studies should be designed to
establish more concrete differences between outcomes of various
treatment modalities for de Quervain's tenosynovitis by using them
in ways that simulate realistic clinical situations.Conclusion
Ketoprofen phonophoresis as an adjunct to a supervised exer-
cise regime and splint immobilisation is a promising therapy for de
Quervain's tenosynovitis during pregnancy. It is safe and provides
symptomatic and functional relief of the condition, which makes it
an ideal therapy for pregnant females. Technique is very important
with any modality, but especially with phonophoresis; the angle of
the sound-head and the speed of sound-head motion could affectTable 6
Palmer pinch strength pretreatment and post-treatment (ketoprofen phonophoresis
for intervention and inert gel for control)
Palmer pinch
strength
Group A (intervention; n ¼ 25) Group B (control; n ¼ 25)
Pretreatment Post-treatment Pretreatment Post-treatment
Mean ± SD 3.86 ± 0.91 8.0 ± 0.56 3.76 ± 0.67 3.63 ± 1.23
Mean difference 4.13 0.4
t value 20.87 1.27
p 0.0001* 0.22
Percentage
of change (%)
106.99 10.63
*p value signiﬁcant.
Third trimester pregnant females (n ¼ 50) complaining of de Quervain's tenosyn-
ovitis of the dominant hand from the outpatient clinic of the obstetrics department,
Kasr-El-Aini University and hospital, Egypt during 2011; ketoprofen 2.5% phono-
phoresis proved highly effective.
SD ¼ standard deviation.
Table 7
Therapeutic outcomes of phonophoresis in numerous clinical trials
Researchers Year Pharmacologic agent Musculoskeletal condition Therapeutic outcome of phonophoresisy (with comments)
Cabak et al7 2005 Ketoprofen gel Epicondylitis of elbow þþþ
Koeke et al8 2005 Hydrocortisone cream Tendon injury and soft tissue damage þ
Cagnie et al9 2003 Ketoprofen gel Knee disorders þ
White10 1991 Piroxicam gel,
benzydamine HCl cream
Osteoarthritis of the knee and
muscular pain
þþ
Airaksinen et al11 1993 Ketoprofen gel Acute soft tissue injury þþ
Gimblett et al12 1999 Movelat cream Calciﬁc tendinitis of the shoulder þþþ (complete resolution of the condition)
Ansari et al13 2013 Erythromycin Chronic maxillary rhinosinusitis þþþ (complete resolution of the condition)
Klaiman et al2 1998 Fluocinonide cream Epicondylitis, tendinitis, and
tenosynovitis
þ (conventional ultrasound therapy was therapeutically equal)
Nagrale et al14 2009 Diclofenac gel Lateral epicondylalgia  (Mills physiotherapy was therapeutically superior)
Kozanoglu et al15 2003 Ibuprofen gel Knee osteoarthritis þ (conventional ultrasound therapy was therapeutically equal)
Jewell et al16 2009 NA* Adhesive capsulitis   (joint mobilisation and exercise were therapeutically superior)
Hasan & Fauzi
(present study)
2014 Ketoprofen gel De Quervain's tenosynovitis þþþ
þþþ ¼ excellent; þþ ¼ very good; þ ¼ good; þ ¼ nil;  ¼ poor;   ¼ very poor.
* Data not available.
y Range of therapeutic outcome.
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physiotherapists can learn what actually works and what does not.Conﬂicts of interest
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